XX Ovarian Dysgenesis Is Caused by a PSMC3IP/HOP2 Mutation that Abolishes Coactivation of Estrogen-Driven Transcription

作者: David Zangen , Yotam Kaufman , Sharon Zeligson , Shira Perlberg , Hila Fridman

DOI: 10.1016/J.AJHG.2011.09.006

关键词: Premature ovarian failureEndocrinologyHypergonadotropic hypogonadismInternal medicineNuclear receptorPSMC3IP GeneFollicle-stimulating hormone receptorGonadal dysgenesisBiologyFollicular atresiaNuclear protein

摘要: XX female gonadal dysgenesis (XX-GD) is a rare, genetically heterogeneous disorder characterized by lack of spontaneous pubertal development, primary amenorrhea, uterine hypoplasia, and hypergonadotropic hypogonadism as result streak gonads. Most cases are unexplained but thought to be autosomal recessive. We elucidated the genetic basis XX-GD in highly consanguineous Palestinian family using homozygosity mapping candidate-gene whole-exome sequencing. Affected females were homozygous for 3 bp deletion (NM_016556.2, c.600_602del) PSMC3IP gene, leading glutamic acid residue (p.Glu201del) conserved C-terminal acidic domain. Proteasome 26S subunit, ATPase, 3-Interacting Protein (PSMC3IP)/Tat Binding Interacting (TBPIP) nuclear, tissue-specific protein with multiple functions. It critical meiotic recombination indicated known role its yeast ortholog, Hop2. Through C terminus (not present yeast), also coactivates ligand-driven transcription mediated estrogen, androgen, glucocorticoid, progesterone, thyroid nuclear receptors. In cell lines, p.Glu201del mutation abolished activation estrogen-driven transcription. Impaired estrogenic signaling can lead ovarian both affecting size follicular pool created during fetal development failing counteract atresia puberty. joins previous genes mutated XX-GD, FSH receptor, BMP15, highlighting importance hormonal maintenance suggesting common pathway perturbed isolated XX-GD. By analogy other genes, candidate gene premature failure, folliculogenesis should further investigated.

参考文章(43)
G. Meduri, A. Bachelot, M.P. Cocca, C. Vasseur, P. Rodien, F. Kuttenn, P. Touraine, M. Misrahi, Molecular pathology of the FSH receptor: new insights into FSH physiology. Molecular and Cellular Endocrinology. ,vol. 282, pp. 130- 142 ,(2008) , 10.1016/J.MCE.2007.11.027
Fumio Otsuka, Kirsten J. McTavish, Shunichi Shimasaki, Integral role of GDF-9 and BMP-15 in ovarian function Molecular Reproduction and Development. ,vol. 78, pp. 9- 21 ,(2011) , 10.1002/MRD.21265
Ralph Scully, Junjie Chen, Annemieke Plug, Yonghong Xiao, David Weaver, Jean Feunteun, Terry Ashley, David M Livingston, Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells Cell. ,vol. 88, pp. 265- 275 ,(1997) , 10.1016/S0092-8674(00)81847-4
A. Fogli, O. Boespflug-Tanguy, The large spectrum of eIF2B-related diseases. Biochemical Society Transactions. ,vol. 34, pp. 22- 29 ,(2006) , 10.1042/BST0340022
I.D. Smith, D.A. Shutt, R.P. Shearman, Foetal plasma steroid concentrations related to gestational age and method of delivery. Journal of Steroid Biochemistry. ,vol. 6, pp. 657- 662 ,(1975) , 10.1016/0022-4731(75)90048-5
Prateek Kumar, Steven Henikoff, Pauline C Ng, Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nature Protocols. ,vol. 4, pp. 1073- 1081 ,(2009) , 10.1038/NPROT.2009.86
K. Wang, M. Li, H. Hakonarson, ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data Nucleic Acids Research. ,vol. 38, ,(2010) , 10.1093/NAR/GKQ603
Bruno Ferraz-de-Souza, Lin Lin, John C. Achermann, Steroidogenic factor-1 (SF-1, NR5A1) and Human Disease Molecular and Cellular Endocrinology. ,vol. 336, pp. 198- 205 ,(2011) , 10.1016/J.MCE.2010.11.006
Sandrine Giscard d’Estaing, Delphine Perrin, Gilbert M. Lenoir, Jean François Guérin, Robert Dante, Upregulation of the BRCA1 gene in human germ cells and in preimplantation embryos Fertility and Sterility. ,vol. 84, pp. 785- 788 ,(2005) , 10.1016/J.FERTNSTERT.2005.02.037